16th Annual Outsourcing in Clinical Trials New England 2024

This year's Outsourcing in Clinical Trials New England event will boast 4 tracks on Clinical Operations and Outsourcing, Clinical Technology and Innovation, Rare Diseases, and Patient Recruitment and Engagement, meaning for anyone involved in the operational aspects of running a clinical trial, there truly is something for everyone.

23 - 24

October

2024
  • Westin Boston Seaport, Boston, USA
  • Complimentary
  • Why attend?
  • Agenda
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

Featured Speakers

Back

JOOST HULSHOF​

Architect, PLP Architecture

Joost has two decades of professional experience with a focus on complex retail, office, master planning, residential projects across Europe and Asia. His site specific and highly contextual design approach capitalises on the urban and environmental potential of each project, and he brings an enriched sense of place that is carefully woven into the fabric of his work. Joost has a wide range of skills covering design, construction detail, project coordination and administration across a range of retail, office, residential, and master planning projects. Integral in his vision for the future of our built environment is his love and passion for the global city and the natural outdoors. This contrast exemplifies that we should be very careful with our scarce space. Densifying and improving our cities, using space smarter, while preserving open space for our wellbeing. He is currently working on an ongoing master plan that rethinks the World Trade Center in Amsterdam, which, when complete, will create an urban business destination providing office space to more than 300 companies and 30 different nationalities. Previously, Joost worked for architectural practices in Amsterdam and Los Angeles. His responsibilities included the master planning, design and construction management of Hoog Catharijne in Utrecht, redeveloping the existing outdated shopping centre into a vibrant mixed-use destination. The award-winning project is one of the largest urban regeneration projects in Europe Other projects include large mixed-use developments in Russia, Czech Republic, France, Germany, Romania, Spain, Turkey, Philippines, China, and the UK. Joost earned his Master of Architecture degree from the faculty of Architecture at the Technical University in Delft, The Netherlands. He also studied a semester at the Escuela Technica Superior de Arquitectura in Madrid, Spain and at the Graduate School of Fine Arts at the University of Pennsylvania in Philadelphia, USA . Joost is a registered Architect in the Netherlands and a member of various professional organizations. He is a member of the ULI Next board in the Netherlands and speaks regularly at conferences and events.

Next speaker

    Sponsors Included:

    Back

    Company Information

    ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 113 locations in 53 countries as at September 30, 2022.

    Company Website

    To learn more , please visit our website - http://www.iconplc.com/

    Next Sponsor
    Back

    Company Information

    Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 33,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,200+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster.

    Company Website

    To learn more , please visit our website - https://www.medidata.com

    Next Sponsor
    Back

    Company Information

    Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase.

    Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.

    The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.

    For more information or to speak to an expert team member visit www.Novotech-CRO.com

    Company Website

    To learn more , please visit our website - www.novotech-cro.com

    Next Sponsor
    Back

    Company Information

    Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, our individualized partnership approach provides experience-driven insights and expertise to assist clients in successfully navigating the complexities of delivering novel treatments to patients.

    Company Website

    To learn more , please visit our website - www.allucent.com

    Next Sponsor
    Back

    Company Information

    ARENSIA Exploratory Medicine, a German company, specializes in “first-in-patient” Phase IB and II/PROOF-OF-CONCEPT clinical trials spanning various patient populations. Equipped with 14 proprietary research clinics and advanced Phase I infrastructure, ARENSIA exceptionally accelerates the detection of initial efficacy signals for novel compounds at an unrivalled speed. ARENSIA’s streamlined approach significantly slashes patient recruitment time and costs by at least 50%, as opposed to overcrowded and understaffed conventional trial sites. The company’s remarkable efficiency is underscored by its 93% repeat business rate, propelling its growth and collaborations with leading pharmaceutical companies, biotechs, and global CROs. H3.eadquartered in Düsseldorf, ARENSIA operates with a workforce of over 450 employees across 8 countries.

    Company Website

    To learn more , please visit our website - http://www.arensia-em.com/

    Next Sponsor
    Back

    Company Information

    Clario is a leading healthcare research and technology company that generates high quality clinical evidence for our pharmaceutical, biotech, and medical device partners. We offer comprehensive evidence generation solutions that combine eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Since our founding more than 50 years ago, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have supported clinical trials over 26,000 times in more than 100 countries.  Our global team of science, technology, and operational experts have supported over 60% of all FDA drug approvals since 2019.

    Company Website

    To learn more , please visit our website - www.Clario.com

    Next Sponsor
    Back

    Company Information

    Emmes is a full service contract research organization collaborating with our clients to produce valued, trusted scientific research. We are known for our superior statistical leadership and data management expertise and proud to have supported  thousands of studies across a diverse range of diseases.  For more than 40 years, Emmes has been dedicated to research for a healthier world.

    Company Website

    To learn more , please visit our website - www.emmes.com

    Next Sponsor
    Back

    Company Information

    PCM Trials has been at the forefront of decentralized clinical research since 2008, leading mobile visits and recently introducing community-based research sites. We are driving the shift to patient-centric clinical trials, giving individuals the flexibility to engage in research studies in ways that work best for them. Our approach expands opportunities for participation, resulting in greater patient diversity, reduced patient dropout, and faster study results.

    Company Website

    To learn more , please visit our website - http://www.pcmtrials.com/

    Next Sponsor
    Back

    Company Information

    Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, CNS, oncology, pediatric, and rare disease.

    Company Website

    To learn more , please visit our website - http://www.premier-research.com/

    Next Sponsor
    Back

    Company Information

    Pro-ficiency converts training from a cost center to a powerful quality improvement system. Our simulation-based protocol training prevents study errors, guarantees timely SIV, and frees up thousands of hours for your study team and site-staff. Pro-ficiency ensures that everyone in your study is compliant with all training requirements.

    Company Website

    To learn more , please visit our website - www.pro-ficiency.com

    Next Sponsor
    Back

    Company Information

    SubjectWell is the risk-free clinical trials marketplace that only charges for patients who randomize. Our unique approach raises awareness of the benefits of clinical research and engages the public when they are not thinking about their conditions. This gives SubjectWell access to tens of millions of patients and when combined with our high-touch approach, allows us to deliver qualified referrals who randomize at three to five times the rate of other sources.

    Company Website

    To learn more , please visit our website - www.SubjectWell.com

    Next Sponsor
    Back

    Company Information

    TFS HealthScience is a global Contract Research Organization (CRO) partnering with biotechnology and pharmaceutical companies throughout their entire clinical development journey. Bringing together nearly 700 professionals, we deliver tailored clinical research services in more than 40 countries. TFS supports customers with comprehensive solutions including full clinical development services, strategic and flexible resourcing. In partnership, we build solution-driven teams of experienced professionals working together for a healthier future. Our mission is to bring treatments to patients faster. For more information, please visit www.tfscro.com.

    Company Website

    To learn more , please visit our website - www.tfscro.com.

    Next Sponsor
    Back

    Company Information

    TransPerfect Life Sciences specializes in supporting the global development and commercialization of drugs, treatments, and devices designed to improve and save lives. Our comprehensive solutions include clinical trial management technology and services (TMF services, eTMF, CTMS, regulated content management, etc.), pharmacovigilance and safety solutions, translation and language services, and call center support. With offices in over 100 cities worldwide, TransPerfect is the ideal partner to ensure that your global launch makes a global impact by driving quality, mitigating compliance risk, and enhancing patient engagement.

    Company Website

    To learn more , please visit our website - https://lifesciences.transperfect.com/

    Next Sponsor
    Back

    Company Information

    Mercalis has a suite of Clinical Trial Support services designed to provide time and cost efficiencies.

    RxStudy Card – Pharmacy provides commercially available medications and supplies through retail and specialty pharmacies. This supply strategy reduces supply process steps, requires less employee time, eliminates supply waste, and has fewer risks resulting in an 80% reduction in labor and a 50% reduction in costs.

    RxStudy Card – Provider provides reimbursement for site sourced and administered medication and is essential for studies requiring biologics and oncolytics, which are more frequently being sourced directly by a provider and not through a pharmacy.

    RxStudy Card – Procurement is an innovative GLOBAL clinical trial supply process that more efficiently provides commercially available medications and supplies. RxStudy Card – Procurement leverages “in country” sourcing and distribution, provides study teams and sites a simple online ordering experience for “just in time” “as needed” delivery, in quantities specific to each site and patients need with direct to site shipments and real time order and shipment status.

    Company Website

    To learn more , please visit our website - www.mercalis.com

    Next Sponsor
    Back

    Company Information

    At Viedoc, we design engaging software that modernizes clinical research so that necessary treatments can reach the people who need them faster. We believe in life and science, in people, and in our collective power to change the world and build a healthier future. That unmatched driving force is what pushes us to innovate, accelerate and improve every aspect of modern clinical studies.

    Company Website

    To learn more , please visit our website - www.viedoc.com

    Next Sponsor
    Back

    Company Information

    Viroclinics-DDL, a Cerba Research Company is a leading specialty contract research organization, serving the biopharmaceutical community with a broad range of non-clinical research, clinical diagnostics, assay development, laboratory, and clinical trial logistic services. It offers its clients a global reach through a network of 38 processing laboratories.

    More Info:

    www.viroclinics.com

    www.ddl.nl

    Company Website

    To learn more , please visit our website - www.viroclinics.com

    Next Sponsor
    Back

    Company Information

    Worldwide is changing how the world experiences CROs – in the best possible way. From early phase, bioanalytical sciences, late phase, post-approval and real-world evidence, Worldwide Clinical Trials provides full-service drug development services for central nervous system, cardiovascular, metabolic, general medicine, oncology and rare disease therapies.

    Company Website

    To learn more , please visit our website - https://www.worldwide.com

    Next Sponsor
    Back

    Company Information

    YPrime’s cloud-based technology streamlines clinical trial data collection and management. Electronic clinical outcome assessments (eCOA) and interactive response technology (IRT) platforms introduce greater speed, precision and data quality to clinical trials. Our consulting services help clients simplify downstream processes, while moving faster and more efficiently to their next development milestone.

    We innovate through pragmatic, forward-looking change that considers the needs of stakeholders in each clinical research role. We’re doing more than streamlining your processes. We’re streamlining your research, helping you get to your next milestone faster.

    Company Website

    To learn more , please visit our website - http://www.yprime.com/

    Next Sponsor
    Back

    Company Information

    Yourway is The Biopharma Services Company changing the landscape of clinical supply chain solutions with a unique, single source model. We are the only truly integrated provider premium courier and clinical packager, supported by a global network of GMP facilities. We have the resources, experience and commitment to make your packaging and shipments faster, and management of trials easier and more efficient. For over 20 years, Yourway has guaranteed speed of delivery with highly customized transport and storage solutions for biopharmaceutical companies, CDMOs and anyone needing to move high value and temperature-sensitive materials around the world. By integrating your clinical packaging seamlessly, we provide unified project management and total visibility.

    Company Website

    To learn more , please visit our website - www.yourway.com

    Next Sponsor
    Back

    Company Information

    IQVIA Technologies help you transform your clinical trials and improve patient safety with SaaS-based applications and tech-enabled services designed to streamline processes, improve workflows, and effectively engage and inform patients. The Orchestrated Clinical Trials (OCT) platform eases the burden on your sites and makes it easier and more appealing for patients to enroll and remain engaged, produces faster trials to database lock, and speeds time to market. For more information visit www.iqvia.com/oct or email us at OrchestrateYourTrials@iqvia.com

     

    Company Website

    To learn more , please visit our website - www.iqvia.com

    Next Sponsor

      Why attend?

      The 16th Annual Outsourcing in Clinical Trials New England event will bring together clinical trial professionals from big and small biopharma to uncover new technologies and processes, to optimize their clinical and outsourcing operations.

      This two day programme will feature four streams on Clinical Operations and Outsourcing, Clinical Technology and Innovation, Patient Recruitment and Engagement, and Rare Diseases, with a mixture of case studies, panel discussions and workshops looking at optimizing your clinical trial strategy. We will explore topics including diversity and inclusion in clinical trials, choosing and working with vendors, the potential uses of AI to increase efficiency in clinical trials, patient centricity in clinical trials, and much much more. Register now to book your place at the conference.

       

      Outsourcing clinical trials can be of particular interest to online casino players. Our Outsourcing in Clinical Trials event in 2023 will consist of 4 tracks, each with something for online casino source link players. In addition, this event will bring together many specialists in clinical trials, who also play in online casinos.

      YOUR CHANCE TO MEET AND CATCH UP WITH COLLEAGUES FROM ACROSS THE INDUSTRY

      As this event returns to an in-person format, you can look forward to a networking focused event with industry leading presentations, interactive formats and the most innovative solution providers attending. Hear from industry leading speakers, Learn what is round the corner in terms of future trends and get the latest knowledge on new and upcoming disruptors.

      • Keynote presentations on the topics affecting you: from COVID to shipping to disruptive technologies
      • Join in with audience discussions, panel debates and add your voice to the conversation

      700+

      Attendees

      		80+

      Exhibitors

      		50+

      Speakers
      700+

      Attendees

      		80+

      Exhibitors
      50+

      Speakers

      Testimonials

      See What It's All About

      Agenda

      • 23 Oct 2024
      • 24 Oct 2024
      Expand All

      Streams

      Stream one

      Stream A: Clinical Outsourcing and Operations

      Stream two

      Stream B: Clinical Technology and Innovation

      Stream three

      Stream C: Patient Recruitment and Engagement

      10:30 AM

      Morning refreshments and networking break

      11 AM

      Best practice for biopharma and advocacy group collaborations in order to boost recruitment for trials

      • How successful collaboration with advocacy groups can boost recruitment and enrolment
      • Strategies for building effective partnerships with advocacy groups
      • Utilizing patient-centric approaches to enhance trial recruitment efforts
      • The impact of a patient-focused trial design on accelerating timelines

      Speakers

      Hollie Schmidt
      Vice President, Scientific Operations, Accelerated Cure Project for MS

      11:30 AM

      Diversity Action Plans: preparing, submitting, and receiving regulatory feedback

      • An overview of recent US legislation around diversity in clinical trials
      • Understanding requirements around DAP approval and submission: what should you include?
      • Preparing documentation to demonstrate diversity in your clinical trial
      • Experience with DAPs in view of the received FDA feedback

      Speakers

      Beatriz Rocha
      Chief Regulatory Liaison Officer, Fortrea

      12 PM

      PANEL: Achieving diversity and inclusion in patient recruitment

      • DEI in rare diseases: how to ensure your trial participants represent the overall population in trials with limited patient numbers
      • Navigating FDA regulations and devising a strategy for diversity and inclusion
      • Building trust and relationships with communities who may not traditionally participate in clinical trials
      • Working with advocacy groups to increase trial diversity and patient numbers

      MODERATOR:

      Robert Loll, Senior Vice President, Business Development and Strategic Planning, Praxis

      Speakers

      Robert Loll
      Senior Vice President, Business Development and Strategic Planning, Praxis
      Patrick Ezeh
      Director, Clinical Trial Diversity Portfolio Lead, Biogen
      Tammy Burke
      Patient Advocate
      Beatriz Rocha
      Chief Regulatory Liaison Officer, Fortrea
      Hasim Khorakiwala
      Associate Director, Global R&D Sourcing, BeiGene
      Behtash Bahador
      Director, Health Literacy, CISCRP

      12:30 PM

      Reserved for Parexel

      1 PM

      Lunch and networking break

      2 PM

      Beyond trial participation: engaging rare disease patients in the long term

      • Biopharma’s role in supporting patients with their disease once no longer study participants
      • Working with advocacy groups on long term patient engagement
      • Where and how can trial sponsors step in to provide long term support for rare disease patients?
      • Bridging the scientific advice gap for patients with rare diseases

      Speakers

      Kate Tith
      Vice President, Head of Clinical Operations, Dyne Therapeutics

      2:30 PM

      Reserved for Rho

      3 PM

      PANEL: How minimizing participant burden leads to on-time enrollment and completion

      • Patient reimbursement: how to relieve financial pressures on patients participating in trials
      • Where are the main hurdles patients face and how can these be removed?
      • Addressing low levels of health literacy in the patient population: how to improve communication
      • Engaging patients and advocacy groups early on in the clinical trial design process

      MODERATOR:

      Leticia Tarilonte, Vice President, Global Clinical Operations, Brainstorm Cell Therapeutics

      Speakers

      Leticia Tarilonte
      Vice President, Global Clinical Operations, Brainstorm Cell Therapeutics
      Colleen Graham
      Vice President, Head of Clinical Operations, Mediar Therapeutics
      Charity Roddy
      Associate Director, Patient and Site Experience, Oncology and Rare Disease, Moderna
      Tammy Burke
      Patient Advocate
      Michele Barber
      Former Associate Director, Patient Engagement, Mural Oncology

      3:30 PM

      Afternoon refreshments and networking break

      3:50 PM

      EXHIBITION APPLE PRIZE DRAW

      Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

      4 PM

      Utilizing technology to improve patient recruitment and retention

      • Methods to streamline patient recruitment and enrolment processes
      • AI and ML as methods of speeding up enrolment timelines in order to reduce overall trial costs
      • Engaging patients through social media and other digital channels

      Speakers

      Jenn Curry
      Head of Patient Engagement Capabilities, Biogen

      4:30 PM

      Reserved for WEP Clinical

      5 PM

      Successful recruitment for a rare disease trial

      • Patient identification: how to find patients who are eligible to participate in your rare disease trial
      • Collaborating with patient advocacy groups to facilitate recruitment
      • How does recruitment in rare diseases differ from other therapeutic areas?

      Speakers

      Chris Adams
      Chief Executive Officer, Andarix

      5:30 PM

      Chairperson’s closing remarks

      Speakers

      Robert Loll
      Senior Vice President, Business Development and Strategic Planning, Praxis

      END OF DAY 1 AND NETWORKING DRINKS

      10:30 AM

      Morning refreshments and networking break

      11 AM

      Reserved for

      Speakers

      Laura Taraboanta
      Director, Medical Operations and Strategy, Click Therapeutics
      Shaheen Lakhan
      Chief Medical Officer, Click Therapeutics

      11:30 AM

      Reserved for IQVIA

      12 PM

      Study results: using AI in clinical development

      • Results of a collaborative industry survey on the use of AI and machine learning within clinical research and development
      • Mapping AI usage and level of adoption
      • Examine perceptions and attitudes regarding use of AI and machine learning and challenges to implementation

      Speakers

      Mary Jo Lamberti
      Research Associate Professor and Director, Sponsored Research, Tufts Center for the Study of Drug Development
      Maria Florez
      Senior Consultant, Tufts Center for the Study of Drug Development

      12:30 PM

      Reserved for Clario

      1 PM

      Lunch and networking break

      2 PM

      PANEL: How do we work together to deliver GenAI for clinical trials?

      • How AI and digitalization can support streamlining of clinical operations and improve efficiency
      • Simple ways to implement tools such as GPT and GenAI
      • Where can AI be utilized to minimize workloads and increase overall output?
      • The regulatory landscape in the US for the use of AI in clinical trials: what do you need to know?
      • Key limitations of GenAI and how these impact its potential uses for clinical trials in the US

      MODERATOR:

      John J. Seman, Chief Executive Officer, REVITALE Pharma

      Speakers

      John J. Seman
      Chief Executive Officer, REVITALE Pharma
      Prasanna Rao
      Senior Director, Global Head of AI and ML, Pfizer
      Ankita Deshpande
      Head, Digital Health and Experience Innovation, Alexion Pharmaceuticals
      Maria Florez
      Senior Consultant, Tufts Center for the Study of Drug Development

      2:30 PM

      Reserved for eClinical Solutions

      2:45 PM

      Reserved for Mednet

      3 PM

      Site activation and study start up: making processes more efficient

      • How early should you begin planning study start up and site activation?
      • Tips and tricks to reduce start up timelines for your trial
      • Fostering a strong relationship with sites to accelerate study start up and reduce overall timelines

      Speakers

      Jay Russak
      Senior Director, Clinical Operations, Keros Therapeutics

      3:30 PM

      Afternoon refreshments and networking break

      3:50 PM

      EXHIBITION APPLE PRIZE DRAW

      Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

      4 PM

      Assessing patient attitudes to the use of AI in clinical trials

      Speakers

      Rebecca Nordland
      Senior Project Manager, CISCRP

      4:30 PM

      Reserved for Viedoc

      5 PM

      eConsent and the benefits for patients, sites, investigators and sponsors

      • Using eConsent as a tool to speed up recruitment and thus overall trial timelines
      • The regulatory landscape surrounding eConsent: what challenges are there to this?
      • Maintaining a relationship with patients in order to ensure consent is informed in remote settings

      Speakers

      Meredith Frank-Molnia
      Senior Director, Clinical Operations, Third Pole Therapeutics

      5:30 PM

      Chairperson’s closing remarks

      Speakers

      Meredith Frank-Molnia
      Senior Director, Clinical Operations, Third Pole Therapeutics

      END OF DAY 1 AND NETWORKING DRINKS

      7:30 AM

      Registration and refreshments

      8:20 AM

      Chair’s opening remarks

      Speakers

      Robert Loll
      Senior Vice President, Business Development and Strategic Planning, Praxis

      8:30 AM

      OPENING PANEL: The clinical trial landscape for small to mid sized biopharma in New England

      • New regulations and guidance around clinical trials in the US: how will this impact you?
      • Staff turnover and layoffs: handling changes in the industry in order to ensure success
      • Navigating the constantly evolving vendor and CRO landscape as a small to mid sized sponsor company
      • An overview of technology and innovation in the clinical trial industry: what’s working and what isn’t?
      • The impact of FDA Project Optimus on running clinical trials in the US

      MODERATOR:

      Revati Tatake, Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Healthcare

      Speakers

      Revati Tatake
      Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Plc
      Harry Barnett
      Executive Chairman And Founder, Lubris BioPharma
      Kevin Killeen
      Chief Scientific Officer, Matrivax
      Nick Pelletier
      Head of Clinical Operations and Program Management, Delix Therapeutics
      Manny Lazaro
      Senior Vice President, Clinical Operations and Data Management, Cerevel Therapeutics

      9 AM

      Reserved for Diligent Pharma

      9:30 AM

      KEYNOTE PRESENTATION: An update on utilizing Generative AI in clinical trials

      • An overview of developments in GenAI and how these can be utilized in clinical trials
      • Use cases and examples of effective use of GenAI in Pfizer’s clinical trials
      • Regulatory considerations when implementing GenAI: what do you need to be aware of?
      • Analyzing the potential of GenAI and how this could revolutionize the clinical trial landscape

      Speakers

      Prasanna Rao
      Senior Director, Global Head of AI and ML, Pfizer

      10 AM

      Reserved for Medidata Solutions

      10:30 AM

      Morning refreshments and networking break

      11 AM

      PANEL: Choosing an outsourcing model: FSO vs FSP vs inhouse

      • Weighing up pros and cons of different outsourcing models: which is best for your trial?
      • When is mixing and matching better than fully outsourcing or keeping trials fully in house?
      • Developing an outsourcing strategy as a small to medium sized biotech with limited resources
      • Why is FSP becoming a popular choice among sponsor companies and how can this support meeting trial timelines?

      MODERATOR:

      John J. Seman, Chief Executive Officer, REVITALE Pharma

      Speakers

      Rinaldo Dorman
      Associate Director, R&D Global Procurement & Strategic Sourcing, Sarepta Therapeutics
      John J. Seman
      Chief Executive Officer, REVITALE Pharma
      Maria de Assis
      Senior Director, Clinical Operations, OriCell Therapeutics
      Judith Murphy
      Executive Director, Centralized Contracting and Outsourcing, Kura Oncology
      Derek Pu
      Director, R&D Procurement, Servier Pharmaceuticals

      11:30 AM

      Reserved for ICON PLC

      12 PM

      Considerations for successful third party vendor management

      • What degree of oversight should you have over third party vendors?
      • Risks and benefits of handing third party management to CROs
      • Regulatory and quality considerations around outsourcing to third party vendors

      Speakers

      Leticia Tarilonte
      Vice President, Global Clinical Operations, Brainstorm Cell Therapeutics

      12:30 PM

      Reserved for Worldwide Clinical Trials

      1 PM

      Lunch and networking break

      2 PM

      Choosing CRO and vendor partners as a small biotech sponsor: priorities and key considerations

      • How vital is knowledge of therapeutic area in CRO selection?
      • As a small biotech, is it beneficial to work with a smaller CRO or a large global CRO?
      • Ensuring your CRO and vendor partners prioritize your study

      Speakers

      Colleen Graham
      Vice President, Head of Clinical Operations, Mediar Therapeutics

      2:30 PM

      Reserved for PCM Trials

      3 PM

      Fostering a productive CRO/Sponsor relationship and factors to consider before undertaking a transition to a new CRO

      • Planning for a successful sponsor/CRO relationship
      • Defining goals, priorities and metrics
      • Considerations when contemplating a CRO transition
      • Overview of common challenges and pitfalls in CRO transitions
      • Developing a detailed transition plan to minimize disruptions and ensure continuity

      Speakers

      Helen Chalk
      Vice President, Clinical Operations, Mythic Therapeutics

      3:30 PM

      Afternoon refreshments and networking break

      3:50 PM

      EXHIBITION APPLE PRIZE DRAW

      Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

      4 PM

      PANEL: Funding, investment and budgeting for clinical trials: tips and best practice to ensure success

      • Top tips for sourcing funding and investment in your trial
      • Overcoming challenges when working with angel investors and VCs to source investment in trials
      • Ensuring your trial is both cost-conscious and efficient without compromising on quality
      • Techniques, processes and technology to improve forecasting and budgeting
      • Avoiding common mistakes to keep your clinical trial budget on track

      MODERATOR:

      Harry Barnett, Executive Chairman, Lubris Biopharma

      Speakers

      Harry Barnett
      Executive Chairman And Founder, Lubris BioPharma
      Veronica Ludensky
      Director of Procurement, Clinical, Flagship Pioneering
      Brenda J Boyle
      Senior Director, Clinical Vendor Strategy and Partnerships, Agios
      Derek Pu
      Director, R&D Procurement, Servier Pharmaceuticals
      Jennifer Sydney Goldman
      Clinical Business Operations Consultant, Day One Biopharmaceuticals

      4:30 PM

      Available for event sponsor

      5 PM

      The state of the biopharmaceutical industry in 2025

      • Reviewing results from our annual survey: were 2024 predictions correct?
      • Key themes and technology advancements in biopharma
      • Spotlight on clinical trial technologies for drug development
      • Leveraging data to predict the outlook for 2025 clinical trial outsourcing
      • Trends, key players, opportunities and threat in biopharma
      • What the latest investment trends show for small to medium biotechs

      Speakers

      Revati Tatake
      Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Plc

      5:30 PM

      Chairperson’s closing remarks

      END OF DAY 1 AND NETWORKING DRINKS

      Streams

      Stream one

      Stream A: Clinical Outsourcing and Operations

      Stream two

      Stream B: Clinical Technology and Innovation

      Stream three

      Stream C: Rare Diseases

      9 AM

      Innovation and digital health for rare diseases

      • Challenges and limitations of rare disease research: how new solutions can help to overcome this
      • Embracing a patient centric approach in rare disease trials through digital health
      • Opportunities for innovation for orphan drug trials in the US

      Speakers

      Ankita Deshpande
      Head, Digital Health and Experience Innovation, Alexion Pharmaceuticals

      9:30 AM

      Available for event sponsor

      10 AM

      PANEL: How to lay the groundwork for a successful rare disease trial through early patient engagement

      • Working closely with patients, caregivers and advocacy groups in clinical trial design
      • The importance of building a close relationship with patients for trials where patients are the expert in their disease
      • Reducing the financial burden of clinical trial participation on patients
      • How to make trial participation easier on patients: where are the main hurdles impacting enrolment?
      • Building long term relationships with patients post clinical trials

      MODERATOR:

      Nan Doyle, Patient Advocate

      Speakers

      Nan Doyle
      Patient Advocate
      Leticia Tarilonte
      Vice President, Global Clinical Operations, Brainstorm Cell Therapeutics
      Michele Barber
      Former Associate Director, Patient Engagement, Mural Oncology
      Lily Cappalletti
      Director, Patient Experience, Alexion Pharmaceuticals
      Janet Peterson
      Associate Director, Patient Insights and Clinical Trial Experience, Biogen
      Sue Kahn
      Board Member, IFOPA

      10:30 AM

      Morning refreshments and networking break

      11 AM

      CASE STUDY: Improving patient and site experience for rare disease trials

      • Sponsors’ roles in supporting sites in order to increase trial efficiency and decrease overall timelines
      • Where can clinical trial sponsors better support patients with rare diseases both during trials and in the long term?
      • Lessons learned from Moderna’s experience of site and patient engagement during clinical trials

       

      Speakers

      Charity Roddy
      Associate Director, Patient and Site Experience, Oncology and Rare Disease, Moderna

      11:30 AM

      Rare disease studies: benefits of a hybrid outsourcing strategy

      A look at the pros and cons of various outsourcing models including Full-Service Outsourcing (FSO), Functional Service Provision (FSP), and single service. A discussion of the benefits of a hybrid approach are explored.

      Speakers

      Ajay Sadhwani
      Senior Vice President, Operations, Harbor Clinic

      12 PM

      Insights into barriers to care in the rare disease community

      • Insights on the differences between represented and underrepresents populations on their barriers to care
      • Challenges and nuances of rare disease patients’ journey to receive a diagnosis
      • Mental health and well-being: the emotional toll rare diseases take on patients and caregivers
      • Exploring overall experiences individuals have had within the healthcare system: strengths and areas for improvement

      Speakers

      Jenifer Waldrop
      Executive Director, Rare Disease Diversity Coalition

      12:30 PM

      Lunch and networking break

      9 AM

      Uncovering RBQM adoption levels and mapping implementation: a novel comprehensive assessment

      • Learn about a new comprehensive approach to assessing RBQM adoption
      • See recent data on current and future levels of RBQM adoption among industry sponsors and CROs
      • Discuss a maturity model that characterizes levels of adoption among industry sponsors
      • Discuss perceived challenges associated with the implementation of RBQM components
      • Discuss opportunities and benefits of RBQM implementation

      Speakers

      Abigail S Dirks
      Data Scientist, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

      9:30 AM

      Reserved for Novotech

      10 AM

      FIRESIDE CHAT: Deploying an effective monitoring strategy

      • Budget considerations
      • In house vs outsourced
      • Site relationship management
      • Effective risk-based approach
      • Remote vs on-site

      Speakers

      Suzanne Murphy
      Director, Clinical Operations, Compliance and Oversight, Editas Med
      Matt Weinberg
      Director, Clinical Outsourcing and Alliance Management, Intellia Therapeutics

      10:30 AM

      Morning refreshments and networking break

      11 AM

      Reserved for

      Speakers

      David Sherris
      Board Member, SiVEC Biotherapeutics

      11:30 AM

      Reserved for TFS HealthScience

      12 PM

      Clinical supply chain procurement challenges in 2024

      • Overview of evolving challenges and solutions in clinical supply chain procurement
      • Examination of the impact of the geopolitical and geoeconomic climate on procurement
      • Regulatory considerations and compliance challenges in clinical supply chain management

      Speakers

      Heng Liu
      Director of Procurement, I-Mab Biopharma

      12:30 PM

      Lunch and networking break

      8 AM

      Registration and Refreshments

      9 AM

      Site relationship management: key ways to develop and maintain effective partnerships with sites

      • How sponsors can support and reduce burden on sites in order to shorten overall trial timelines
      • Top tips for training site staff with new processes and technology
      • Managing relationships with short staffed and under resourced sites to ensure your trial stays on track

      Speakers

      Marilyn Fontaine
      Director of Clinical Operations, Nuvation Bio

      9:30 AM

      Reserved for Allucent

      10 AM

      Navigating multiple regulatory agencies to help expedite supply chain times

      • Understanding the requirement and options for declaring biological materials to U.S. Customs and Border Protection (CBP)
      • Review of key U.S. regulatory agency authorities, such as CDC, FDA, USDA, and CBP
      • Discovering the latest non-compliant shipment issues for biological materials and pharma products and tips to avoid them
      • Learning about valuable resources and contacts for assistance

      Speakers

      Sean Smith
      Biological Threat Exclusion Coordinator (BTEC), Agriculture Programs and Trade Liaison, Office of Field Operations, U.S. Customs and Border Protection

      10:30 AM

      Morning refreshments and networking break

      11 AM

      PANEL: Fostering a strong relationship with your CRO to make your trial a success

      • Technology and new developments when it comes to managing CRO relationships
      • How to ensure your study is prioritized
      • Maintaining a strong relationship with vendors in remote and hybrid work settings
      • How to blend a CRO team with your internal team in order to foster communication and overall success of your trial
      • CRO monitoring and oversight: how to make processes efficient and effective

      MODERATOR:

      Leonella Seeley, Director, Vendor Management and Operations, Karyopharm Therapeutics

      Speakers

      Leonella Seeley
      Associate Director Of Vendor Management And Operations, Karyopharm Therapeutics
      Yolanda Wan
      Head of Clinical Operations, Orna Therapeutics
      Molly James
      Associate Director, Strategic Sourcing, Beam Therapeutics
      Brenda J Boyle
      Senior Director, Clinical Vendor Strategy and Partnerships, Agios
      Judith Murphy
      Executive Director, Centralized Contracting and Outsourcing, Kura Oncology

      11:30 AM

      Reserved for Premier Research

      12 PM

      Best practices in contracting and budget negotiation in order to minimize cost

      • Sourcing vendors for your trial while remaining cost-conscious
      • Strategies for negotiating with supplier and CRO partners
      • Successful approaches to contracting and budget negotiation in clinical trials
      • Practical tips and tools to minimize cost and maximize value

      Speakers

      Milica Kakarla
      Vendor Contracts Lead, Biogen

      12:30 PM

      Lunch and networking break

      1:30 PM

      KEYNOTE PRESENTATION: Report Card on the use and impact of patient engagement practices in drug development

      • Overview of the value proposition and expected financial return of patient engagement practices
      • Review of current adoption levels of patient engagement practices
      • Assessment of the impact of patient engagement practices on performance and quality
      • Discussion of opportunities to optimize patient engagement and its impact

      Speakers

      Ken Getz
      Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

      2:15 PM

      Efficient data orchestration in your clinical trials

      • Understand key gateways to ensure quality and coordination
      • Advantages of using a single CRO to manage all data related activities
      • Simplifying process where achievable to reduce risk and cost

      Speakers

      Eric Harvey
      Senior Director, Biometrics and Data Science, MMS

      2:45 PM

      Frustrations of a CRO sales guy, or, a guided tour of the clinical trial outsourcing world, from both sides of the negotiation table

      Speakers

      David Gibboni
      Independent Clinical Outsourcing Expert

      3:15 PM

      KEYNOTE PANEL: Where is the clinical trial industry headed in 2025?

      • Navigating new regulations around clinical trials smoothly and successfully
      • The impact of artificial intelligence: how far can we expect to move forward in the next 12 months?
      • Patient centricity in clinical trials: how can burden be reduced in order to make trials easier for patients to participate in?
      • How may geopolitical and geoeconomic events including the financial crisis, the Inflation Reduction Act and the upcoming election impact clinical trials in the US?
      • Technological developments into 2025 and beyond: what changes can we expect to see in the next 3-5 years?

      MODERATOR:

      Revati Tatake, Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Healthcare

      Speakers

      Revati Tatake
      Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Plc
      Jay Russak
      Senior Director, Clinical Operations, Keros Therapeutics
      Harry Barnett
      Executive Chairman And Founder, Lubris BioPharma
      Rinaldo Dorman
      Associate Director, R&D Global Procurement & Strategic Sourcing, Sarepta Therapeutics
      Manny Lazaro
      Senior Vice President, Clinical Operations and Data Management, Cerevel Therapeutics

      3:45 PM

      Afternoon refreshments and networking break

      4:10 PM

      EXHIBITION APPLE PRIZE DRAW

      Visit our exhibitors’ booths throughout the conference and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

      4:15 PM

      PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

      During the roundtable discussion session, the conference hall will be divided into four ‘zones’. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within clinical operations. Roundtables will take place in the Stream A conference room.

      ROUNDTABLE 1: Importing and exporting biological materials to or from the U.S

      Sean D. Smith, Biological Threat Exclusion Coordinator (BTEC), U.S. Customs and Border Protection
      ROUNDTABLE 2: Pros and cons of different outsourcing models: FSO vs FSP vs inhouse

      Yolanda Wan, Head of Clinical Operations, Orna Therapeutics
      ROUNDTABLE 3: Enabling the most inclusive approach to patient engagement

      Lily Cappalletti, Director, Patient Experience, Alexion Pharmaceuticals
      ROUNDTABLE 4: Topic TBC

      Kate Tith, Vice President, Head of Clinical Operations, Dyne Therapeutics
      ROUNDTABLE 5: Building efficient and effective relationships with sites

      Peter Koefler, Director, Study Site Engagement, Takeda
      ROUNDTABLE 6: Choosing the right technology vendors for clinical data management

      Cory Burke, Executive Director, Head of Biometrics and Data Management, Black Diamond Therapeutics

      Speakers

      Sean Smith
      Biological Threat Exclusion Coordinator (BTEC), Agriculture Programs and Trade Liaison, Office of Field Operations, U.S. Customs and Border Protection
      Yolanda Wan
      Head of Clinical Operations, Orna Therapeutics
      Lily Cappalletti
      Director, Patient Experience, Alexion Pharmaceuticals
      Kate Tith
      Vice President, Head of Clinical Operations, Dyne Therapeutics
      Peter Koefler
      Director, Study Site Engagement, Takeda
      Cory Burke
      Executive Director, Head of Biometrics and Data Management, Black Diamond Therapeutics

      End of Conference

      Speakers

      Select a speaker to learn more

      Back
      Ken Getz
      Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

      Ken is the Director of Sponsored Research and Associate Professor at the Tufts Center for the Study of Drug Development, and Chairman of the Center for Information and Study on Clinical Research Participation, a non-profit organization that he founded to raise public and patient awareness of the clinical research enterprise. He is founder and owner of CenterWatch, and an owner and board member of the Metrics Champion Consortium. A well-known speaker at symposia, universities, and corporations, Ken has published extensively in peer-reviewed journals, books and in the trade press.  He has been an active DIA member for 25 years and has held board appointments in the private and public sectors.  Ken earned his MBA from Northwestern University.

      Session Details:

      KEYNOTE PRESENTATION: Report Card on the use and impact of patient engagement practices in drug development

      2024-10-24, 1:30 PM

      View In Agenda
      Next speaker
      Back
      Hollie Schmidt
      Vice President, Scientific Operations, Accelerated Cure Project for MS

      Hollie Schmidt is the VP of Scientific Operations at Accelerated Cure Project for Multiple Sclerosis. She co-chairs the Research Committee of iConquerMS™, a research cohort established to perform and support patient-centered research in MS. She also founded and leads the MS Minority Research Engagement Partnership Network, a multi-stakeholder initiative aimed at increasing racial and ethnic diversity in MS research studies.

      Session Details:

      Best practice for biopharma and advocacy group collaborations in order to boost recruitment for trials

      2024-10-23, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Brenda J Boyle
      Senior Director, Clinical Vendor Strategy and Partnerships, Agios

      Session Details:

      PANEL: Funding, investment and budgeting for clinical trials: tips and best practice to ensure success

      2024-10-23, 4:00 PM

      Session Details:

      PANEL: Fostering a strong relationship with your CRO to make your trial a success

      2024-10-24, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Ankita Deshpande
      Head, Digital Health and Experience Innovation, Alexion Pharmaceuticals

      Session Details:

      PANEL: How do we work together to deliver GenAI for clinical trials?

      2024-10-23, 2:00 PM

      Session Details:

      Innovation and digital health for rare diseases

      2024-10-24, 9:00 AM

      View In Agenda
      Next speaker
      Back
      Lily Cappalletti
      Director, Patient Experience, Alexion Pharmaceuticals

      Session Details:

      PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

      2024-10-24, 4:15 PM

      Session Details:

      PANEL: How to lay the groundwork for a successful rare disease trial through early patient engagement

      2024-10-24, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Chris Adams
      Chief Executive Officer, Andarix

      Mr. Adams has been a founder or co-founder of life science and technology based companies in Massachusetts for the past several years. Mr. Adams has been instrumental in developing new proprietary therapeutic and medical device technologies and bringing the technologies to commercialization. The companies he has founded include, Compellis Pharmaceuticals, a developer of therapeutics to treat obesity and its co-morbidities, diabetes and hypertension and Mosaic Technologies, a venture backed MIT spin-out genomics company that developed patented technologies for genetic analysis and detection. Chris is the holder of more than 20 issued US and international patents for medical devices and pharmaceuticals.

      Session Details:

      Successful recruitment for a rare disease trial

      2024-10-23, 5:00 PM

      View In Agenda
      Next speaker
      Back
      Marilyn Fontaine
      Director of Clinical Operations, Nuvation Bio

      Session Details:

      Site relationship management: key ways to develop and maintain effective partnerships with sites

      2024-10-24, 9:00 AM

      View In Agenda
      Next speaker
      Back
      Molly James
      Associate Director, Strategic Sourcing, Beam Therapeutics

      Session Details:

      PANEL: Fostering a strong relationship with your CRO to make your trial a success

      2024-10-24, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Hasim Khorakiwala
      Associate Director, Global R&D Sourcing, BeiGene

      Session Details:

      PANEL: Achieving diversity and inclusion in patient recruitment

      2024-10-23, 12:00 PM

      View In Agenda
      Next speaker
      Back
      Patrick Ezeh
      Director, Clinical Trial Diversity Portfolio Lead, Biogen

      Session Details:

      PANEL: Achieving diversity and inclusion in patient recruitment

      2024-10-23, 12:00 PM

      View In Agenda
      Next speaker
      Back
      Milica Kakarla
      Vendor Contracts Lead, Biogen

      Session Details:

      Best practices in contracting and budget negotiation in order to minimize cost

      2024-10-24, 12:00 PM

      View In Agenda
      Next speaker
      Back
      Jenn Curry
      Head of Patient Engagement Capabilities, Biogen

      Session Details:

      Utilizing technology to improve patient recruitment and retention

      2024-10-23, 4:00 PM

      View In Agenda
      Next speaker
      Back
      Janet Peterson
      Associate Director, Patient Insights and Clinical Trial Experience, Biogen

      Session Details:

      PANEL: How to lay the groundwork for a successful rare disease trial through early patient engagement

      2024-10-24, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Cory Burke
      Executive Director, Head of Biometrics and Data Management, Black Diamond Therapeutics

      Cory Burke is the Executive Director Head of Biometrics and Data Management at Black Diamond Therapeutics. Cory has over 25 years of experience in the pharmaceutical industry in both CRO and Sponsor side. She has worked in many aspects of data management, database programming and SAS programming in the industry. She works collaboratively with Clinical Operations, Medical, Translational Medicine and many other cross functional teams. She has worked on a wide range of therapeutic areas (Oncology, Dermatology, Cardiology, Gastrologic,etc) from Phase I-IV.

      Session Details:

      PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

      2024-10-24, 4:15 PM

      View In Agenda
      Next speaker
      Back
      Leticia Tarilonte
      Vice President, Global Clinical Operations, Brainstorm Cell Therapeutics

      Session Details:

      Considerations for successful third party vendor management

      2024-10-23, 12:00 PM

      Session Details:

      PANEL: How minimizing participant burden leads to on-time enrollment and completion

      2024-10-23, 3:00 PM

      Session Details:

      PANEL: How to lay the groundwork for a successful rare disease trial through early patient engagement

      2024-10-24, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Rebecca Nordland
      Senior Project Manager, CISCRP

      Session Details:

      Assessing patient attitudes to the use of AI in clinical trials

      2024-10-23, 4:00 PM

      View In Agenda
      Next speaker
      Back
      Laura Taraboanta
      Director, Medical Operations and Strategy, Click Therapeutics

      Laura Taraboanta, MS is a clinical strategy and development professional with a demonstrated history in health care and clinical trials. She is currently the of Head Clinical Innovation at Click Therapeutics, with a focus on improving speed, efficiency, and cost of prescription digital therapeutics discovery, development and implementation. Prior to Click, Laura was leading clinical operations at Woebot Health, a mental health company focused on delivering evidence-based treatment through an AI chatbot. Laura has been part of two successful FDA Breakthrough Designations for software as medical devices and has overseen numerous research projects in CNS and oncology, tapping into the potential of virtual trials to empower patients. Laura is keen on tackling health disparities by accelerating digital therapeutic development so that clinically-proven, safe and effective solutions can be universally available to patients and their providers.

      Session Details:

      Reserved for

      2024-10-23, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Shaheen Lakhan
      Chief Medical Officer, Click Therapeutics

      Session Details:

      Reserved for

      2024-10-23, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Manny Lazaro
      Senior Vice President, Clinical Operations and Data Management, Cerevel Therapeutics

      Session Details:

      OPENING PANEL: The clinical trial landscape for small to mid sized biopharma in New England

      2024-10-23, 8:30 AM

      Session Details:

      KEYNOTE PANEL: Where is the clinical trial industry headed in 2025?

      2024-10-24, 3:15 PM

      View In Agenda
      Next speaker
      Back
      Nick Pelletier
      Head of Clinical Operations and Program Management, Delix Therapeutics

      Session Details:

      OPENING PANEL: The clinical trial landscape for small to mid sized biopharma in New England

      2024-10-23, 8:30 AM

      View In Agenda
      Next speaker
      Back
      Kate Tith
      Vice President, Head of Clinical Operations, Dyne Therapeutics

      Session Details:

      Beyond trial participation: engaging rare disease patients in the long term

      2024-10-23, 2:00 PM

      Session Details:

      PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

      2024-10-24, 4:15 PM

      View In Agenda
      Next speaker
      Back
      Suzanne Murphy
      Director, Clinical Operations, Compliance and Oversight, Editas Med

      Session Details:

      FIRESIDE CHAT: Deploying an effective monitoring strategy

      2024-10-24, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Veronica Ludensky
      Director of Procurement, Clinical, Flagship Pioneering

      Session Details:

      PANEL: Funding, investment and budgeting for clinical trials: tips and best practice to ensure success

      2024-10-23, 4:00 PM

      View In Agenda
      Next speaker
      Back
      Beatriz Rocha
      Chief Regulatory Liaison Officer, Fortrea

      Session Details:

      PANEL: Achieving diversity and inclusion in patient recruitment

      2024-10-23, 12:00 PM

      Session Details:

      Diversity Action Plans: preparing, submitting, and receiving regulatory feedback

      2024-10-23, 11:30 AM

      View In Agenda
      Next speaker
      Back
      Revati Tatake
      Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Plc

      Revati Tatake, PhD, is the Global Head of Pharma Research, Analysis and Competitive Intelligence at GlobalData Healthcare.  Revati has over 25 years of multidisciplinary experience in academic research and the healthcare industry, both on the client and agency sides of the business. Previously she worked as a VP of Databases and Analytics at GlobalData, where she made significant contributions to Pharma Intelligence Center. Before joining GlobalData, Revati worked at Citeline/Informa, where she was involved in competitive intelligence and analytics of clinical trials and drugs in the areas of Autoimmune/Inflammation, Central Nervous System, and Ophthalmology.  Earlier, Revati worked at Boehringer Ingelheim Pharmaceuticals for over 12 years as Senior Scientist to Senior Principal Scientist, where she led drug discovery projects involving traditional high-throughput screening, as well as innovative approaches for gene and cell therapies. She also worked at Boehringer Ingelheim as a Director of Competitive Intelligence for projects in cardiometabolic space and research beyond borders. She is a co-inventor on many issued US patents related cell and gene therapies and has several publications in peer reviewed scientific journals. Revati holds a PhD in Tumor Immunology from the Tata Cancer Research Institute in Mumbai, India. She did her postdoctoral fellowship at the University of Connecticut Health Center and Boehringer Ingelheim.

      Session Details:

      OPENING PANEL: The clinical trial landscape for small to mid sized biopharma in New England

      2024-10-23, 8:30 AM

      Session Details:

      The state of the biopharmaceutical industry in 2025

      2024-10-23, 5:00 PM

      Session Details:

      KEYNOTE PANEL: Where is the clinical trial industry headed in 2025?

      2024-10-24, 3:15 PM

      View In Agenda
      Next speaker
      Back
      Ajay Sadhwani
      Senior Vice President, Operations, Harbor Clinic

      Session Details:

      Rare disease studies: benefits of a hybrid outsourcing strategy

      2024-10-24, 11:30 AM

      View In Agenda
      Next speaker
      Back
      Sue Kahn
      Board Member, IFOPA

      Session Details:

      PANEL: How to lay the groundwork for a successful rare disease trial through early patient engagement

      2024-10-24, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Heng Liu
      Director of Procurement, I-Mab Biopharma

      Session Details:

      Clinical supply chain procurement challenges in 2024

      2024-10-24, 12:00 PM

      View In Agenda
      Next speaker
      Back
      Matt Weinberg
      Director, Clinical Outsourcing and Alliance Management, Intellia Therapeutics

      Session Details:

      FIRESIDE CHAT: Deploying an effective monitoring strategy

      2024-10-24, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Leonella Seeley
      Associate Director Of Vendor Management And Operations, Karyopharm Therapeutics

      Session Details:

      PANEL: Fostering a strong relationship with your CRO to make your trial a success

      2024-10-24, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Jay Russak
      Senior Director, Clinical Operations, Keros Therapeutics

      Session Details:

      Site activation and study start up: making processes more efficient

      2024-10-23, 3:00 PM

      Session Details:

      KEYNOTE PANEL: Where is the clinical trial industry headed in 2025?

      2024-10-24, 3:15 PM

      View In Agenda
      Next speaker
      Back
      Judith Murphy
      Executive Director, Centralized Contracting and Outsourcing, Kura Oncology

      Session Details:

      PANEL: Choosing an outsourcing model: FSO vs FSP vs inhouse

      2024-10-23, 11:00 AM

      Session Details:

      PANEL: Fostering a strong relationship with your CRO to make your trial a success

      2024-10-24, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Harry Barnett
      Executive Chairman And Founder, Lubris BioPharma

      Harry Barnett Harry is the co-founder and Executive Chairman of Lubris BioPharma, a clinical-stage biotech company developing a proprietary version of the novel, ubiquitous human protein, PRG4, for use in multiple indications.  Novartis owns rights to Lubris’ technology for ophthalmology. Harry’s two-decade life science career includes: (i) co-founding and executive management roles at three life science companies and two CROs; (ii) incubating, partnering and licensing successfully a wide array of pharmaceutical products and technologies including Pepcid Complete®, the OTC hearburn remedy sold by J&J, and; (iii) innovating multi-center, clinical trial processes using techniques that have been adopted as industry standard.  Prior to his transition to life science and biotech, Harry was a transactional business lawyer in private practice at DLA Piper in San Diego, and later at Faneuil Advisors, Inc., an investment advisory firm based in Boston where he served as General Counsel and Executive Vice President.

      Session Details:

      OPENING PANEL: The clinical trial landscape for small to mid sized biopharma in New England

      2024-10-23, 8:30 AM

      Session Details:

      PANEL: Funding, investment and budgeting for clinical trials: tips and best practice to ensure success

      2024-10-23, 4:00 PM

      Session Details:

      KEYNOTE PANEL: Where is the clinical trial industry headed in 2025?

      2024-10-24, 3:15 PM

      View In Agenda
      Next speaker
      Back
      Kevin Killeen
      Chief Scientific Officer, Matrivax

      Session Details:

      OPENING PANEL: The clinical trial landscape for small to mid sized biopharma in New England

      2024-10-23, 8:30 AM

      View In Agenda
      Next speaker
      Back
      Colleen Graham
      Vice President, Head of Clinical Operations, Mediar Therapeutics

      Colleen Graham has over 20 years of extensive Clinical Research experience. She began her research career at a Clinical Site, and has held a variety of operational positions from an Ethical Review Board to CROs and Pharmaceutical companies, both large and small. Her experience includes Phases I-IV drugs, biologics and device studies across a variety of therapeutic areas working with companies such as Biogen, Pfizer, and Takeda Pharmaceuticals. Her operational experience includes resource management, process development and she has managed large-scale global studies. Colleen is currently Director of Clinical Development Operations at Momenta Pharmaceuticals, where she responsible for clinical development of M281 in rare immune-mediated diseases.

      Session Details:

      Choosing CRO and vendor partners as a small biotech sponsor: priorities and key considerations

      2024-10-23, 2:00 PM

      Session Details:

      PANEL: How minimizing participant burden leads to on-time enrollment and completion

      2024-10-23, 3:00 PM

      View In Agenda
      Next speaker
      Back
      Eric Harvey
      Senior Director, Biometrics and Data Science, MMS

      Session Details:

      Efficient data orchestration in your clinical trials

      2024-10-24, 2:15 PM

      View In Agenda
      Next speaker
      Back
      Michele Barber
      Former Associate Director, Patient Engagement, Mural Oncology

      Session Details:

      PANEL: How minimizing participant burden leads to on-time enrollment and completion

      2024-10-23, 3:00 PM

      Session Details:

      PANEL: How to lay the groundwork for a successful rare disease trial through early patient engagement

      2024-10-24, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Helen Chalk
      Vice President, Clinical Operations, Mythic Therapeutics

      Session Details:

      Fostering a productive CRO/Sponsor relationship and factors to consider before undertaking a transition to a new CRO

      2024-10-23, 3:00 PM

      View In Agenda
      Next speaker
      Back
      Maria de Assis
      Senior Director, Clinical Operations, OriCell Therapeutics

      Session Details:

      PANEL: Choosing an outsourcing model: FSO vs FSP vs inhouse

      2024-10-23, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Yolanda Wan
      Head of Clinical Operations, Orna Therapeutics

      Yolanda is the Vice-President of Clinical Operations at Accutar Biotechnology. She brings along 17 years of experience in Clinical Development, with focus on both Clinical Operations and Clinical Project Management. Her areas of expertise include strategic operations planning at the compound-level; first-in-human study planning & adaptive execution in therapeutic areas of oncology and ophthalmology. Leadership with cross-functional teams has included the development and implementation of governance and operational strategy, optimizing processes and building dynamic teams to exceed business objectives. Prior to joining Accutar, she held various positions at Bayer in the US and a number of countries within Asia. This attributes to her extensive knowledge of bridging-strategy between the two continents.

      Session Details:

      PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

      2024-10-24, 4:15 PM

      Session Details:

      PANEL: Fostering a strong relationship with your CRO to make your trial a success

      2024-10-24, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Nan Doyle
      Patient Advocate

      Nan Doyle is a patient engagement catalyst with a passion to strengthen access to diagnosis and treatment for people living with rare genetic conditions. She has deep roots in medicines development, and is known for building durable relationships based on a foundation of active listening and inquiry.
      Most recently, Nan established and built the Rare Disease Patient Engagement function for Takeda Pharmaceuticals. The role required strategy-driven partnerships with patient organizations; and tight, de-siloed collaboration with R&D, Clinical Development, Commercial, Regulatory, Access, and other colleagues around the world.
      Nan is also a board-certified genetic counselor, where she developed front-line understanding of patient and care partner practical, emotional, financial and policy needs.

      Session Details:

      PANEL: How to lay the groundwork for a successful rare disease trial through early patient engagement

      2024-10-24, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Tammy Burke
      Patient Advocate

      Session Details:

      PANEL: Achieving diversity and inclusion in patient recruitment

      2024-10-23, 12:00 PM

      Session Details:

      PANEL: How minimizing participant burden leads to on-time enrollment and completion

      2024-10-23, 3:00 PM

      View In Agenda
      Next speaker
      Back
      Prasanna Rao
      Senior Director, Global Head of AI and ML, Pfizer

      Prasanna Rao is an AI practitioner and Industry Thought Leader whose current role is Head of Artificial Intelligence and Data Science for Data Management at Pfizer. He has 30 years of experience in Information technology and Analytics, with 10+ years in Healthcare and Life Sciences. In his previous role as a Watson Solution Architect at IBM, he was instrumental in implementing many different AI systems from idea to implementation with various clients. In his current role, he works with various stakeholders, vendors, business SMEs, Machine Learning developers, and Data Scientists to deliver innovation and drive adoption of AI. He has presented at several industry conferences including SCDM, DIA and SCOPE.

      Session Details:

      KEYNOTE PRESENTATION: An update on utilizing Generative AI in clinical trials

      2024-10-23, 9:30 AM

      Session Details:

      PANEL: How do we work together to deliver GenAI for clinical trials?

      2024-10-23, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Robert Loll
      Senior Vice President, Business Development and Strategic Planning, Praxis

      Robert Loll is the SVP of Business Development & Strategic Planning at Praxis, a full service patient recruitment & retention agency that specializes in optimizing study enrollment for research studies with award-winning creative and superior execution.  Designing and deploying effective patient recruitment campaign strategies since 2004, Robert’s clinical background includes 16+ years providing patient care for top collegiate, Olympic and disabled athletes around the world and working for outpatient rehabilitation companies including Baxter, Caremark and NovaCare.  Robert is an Advisory Board member for The Center for Information and Study on Clinical Research Participation (CISCRP), an independent non-profit organization dedicated to educating and informing the public and patients about clinical research.

      Session Details:

      Chair’s opening remarks

      2024-10-23, 8:20 AM

      Session Details:

      PANEL: Achieving diversity and inclusion in patient recruitment

      2024-10-23, 12:00 PM

      Session Details:

      Chairperson’s closing remarks

      2024-10-23, 5:30 PM

      View In Agenda
      Next speaker
      Back
      Jenifer Waldrop
      Executive Director, Rare Disease Diversity Coalition

      Jenifer Ngo Waldrop joined the Black Women’s Health Imperative (BWHI) as Executive Director of the Rare Disease Diversity Coalition (RDDC) in October 2022. Before joining the leadership team of RDDC, she developed models and programs for diversity, equity, and inclusion initiatives to support multiple business units with Fortune 500 companies and organizations in Asia, Canada, and the US.

      Jenifer has led initiatives at non-profit organizations where she recruited local community members to participate in numerous health-related fundraising events and developed programs to target disparities and underrepresented groups. In addition to facilitating development and fundraising, Jenifer developed a reputation for successful coalition building.

      Jenifer received her undergraduate degree from Colby College and her Master of Human Resources Development from Villanova. As the Professional Development Director of the National Association of Asian-American Professionals (NAAAP) of Colorado, Jenifer continues her outreach in society. Through this organization, she mentors formally and informally.

      Next speaker
      Back
      John J. Seman
      Chief Executive Officer, REVITALE Pharma

      John Seman is the CEO and Founder of REVITALE Pharma.  He began his career working in Big Pharma - Johnson & Johnson and Bristol Myers Squibb - in sales, marketing and business development.  The second half of his career was spent as a serial entrepreneur having Founded a half dozen companies that provided either products or services for the pharmaceutical industry.  John earned his bachelor's and master's degrees from the Massachusetts College of Pharmacy.

      Session Details:

      PANEL: How do we work together to deliver GenAI for clinical trials?

      2024-10-23, 2:00 PM

      Session Details:

      PANEL: Choosing an outsourcing model: FSO vs FSP vs inhouse

      2024-10-23, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Rinaldo Dorman
      Associate Director, R&D Global Procurement & Strategic Sourcing, Sarepta Therapeutics

      Rinaldo leads the Clinical Procurement team at Sarepta Therapeutics; which focuses on the clinical trial outsourcing for phases 1 through 3. His tenure as a Procurement professional includes roles at large and small organizations across both pharmaceuticals as well as biotech organizations. He has an MBA from Northeastern University and is a Certified Professional of Supply Management.

      Session Details:

      PANEL: Choosing an outsourcing model: FSO vs FSP vs inhouse

      2024-10-23, 11:00 AM

      Session Details:

      KEYNOTE PANEL: Where is the clinical trial industry headed in 2025?

      2024-10-24, 3:15 PM

      View In Agenda
      Next speaker
      Back
      Derek Pu
      Director, R&D Procurement, Servier Pharmaceuticals

      Session Details:

      PANEL: Funding, investment and budgeting for clinical trials: tips and best practice to ensure success

      2024-10-23, 4:00 PM

      Session Details:

      PANEL: Choosing an outsourcing model: FSO vs FSP vs inhouse

      2024-10-23, 11:00 AM

      View In Agenda
      Next speaker
      Back
      David Sherris
      Board Member, SiVEC Biotherapeutics

      Session Details:

      Reserved for

      2024-10-24, 11:00 AM

      View In Agenda
      Next speaker
      Back
      Peter Koefler
      Director, Study Site Engagement, Takeda

      Session Details:

      PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

      2024-10-24, 4:15 PM

      View In Agenda
      Next speaker
      Back
      Meredith Frank-Molnia
      Senior Director, Clinical Operations, Third Pole Therapeutics

      Meredith Frank-Molnia is currently employed at Third Pole Therapeutics as Senior Director of Clinical Operations. Third Pole is a medical device company producing electrically generated nitric oxide for treatment of hypoxic respiratory failure and lung disease.  Previously, Meredith held the position of Senior Director Clinical Management, while working at Axiom Real-Time Metrics Inc., where she established and expanded their Clinical Management department. Meredith has been in Clinical Project Management/Operations for 26 years in numerous roles of increasing responsibilities. Meredith has worked managing device/biologic and drug studies.

      Session Details:

      eConsent and the benefits for patients, sites, investigators and sponsors

      2024-10-23, 5:00 PM

      Session Details:

      Chairperson’s closing remarks

      2024-10-23, 5:30 PM

      View In Agenda
      Next speaker
      Back
      Mary Jo Lamberti
      Research Associate Professor and Director, Sponsored Research, Tufts Center for the Study of Drug Development

      Mary Jo Lamberti is a Research Associate Professor at Tufts University Medical School and Director of Sponsored Research at the Tufts Center for the Study of Drug Development. She has extensive experience on benchmarking drug development operating practices. Her research focuses on a variety of areas including outsourcing and partnerships, clinical research workforce issues, investigative site initiation and management, patient recruitment and retention, and the use of technologies and digital solutions in clinical trials. She has been a frequent speaker at global industry conferences and has published extensively. She holds a B.A. from Wellesley College and a Ph.D. from Boston University.

      Session Details:

      Study results: using AI in clinical development

      2024-10-23, 12:00 PM

      View In Agenda
      Next speaker
      Back
      Abigail S Dirks
      Data Scientist, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

      Abigail Dirks is a Data Scientist at the Tufts Center for the Study of Drug Development (Tufts CSDD) where she specializes in analyzing large datasets pertaining to industry drug development performance, including clinical research associate (CRA) performance, impact of decentralized clinical trials (DCT), and investigative site burden. She recently received her Master’s in Health Informatics and Analytics from Tufts University and has a BS in Data Science and Mathematics from St. Michael’s College. She also has experience in web development for North Shore Nurse Practitioner Associates, a psychopharmacology practice.

      Session Details:

      Uncovering RBQM adoption levels and mapping implementation: a novel comprehensive assessment

      2024-10-24, 9:00 AM

      View In Agenda
      Next speaker
      Back
      Maria Florez
      Senior Consultant, Tufts Center for the Study of Drug Development

      Session Details:

      Study results: using AI in clinical development

      2024-10-23, 12:00 PM

      Session Details:

      PANEL: How do we work together to deliver GenAI for clinical trials?

      2024-10-23, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Sean Smith
      Biological Threat Exclusion Coordinator (BTEC), Agriculture Programs and Trade Liaison, Office of Field Operations, U.S. Customs and Border Protection

      Sean Smith is a Biological Threat Exclusion Coordinator (BTEC) for CBP in the Office of Field Operations/ Agriculture Programs and Trade Liaison/ Agro/Bio-Terrorism Countermeasures. As a BTEC, Mr. Smith is charged with supporting and developing U.S. Customs and Border Protection (CBP) operational capacity and capability in preventing tools of agro/bio-terrorism from entering the U.S.

      Mr. Smith joined CBP in 2005 as an Agriculture Specialist (CBPAS) and was promoted to Supervisory CBPAS in 2008. He has served CBP in the following ports of entry: San Diego, San Ysidro, Otay Mesa and Boston Logan Airport. From 2011- 2018, Mr. Smith served as the primary Public Affairs Liaison and Border Community Liaison, respectively, for CBP in New England. He has also volunteered to assist in past domestic and international CBP disaster recovery operations, including: Hurricane Ike (2008), 'Operation Safe Return' (Haitian Relief Effort- 2010), and Hurricane Harvey, DHS Surge Capacity Force (2017).

      Prior to CBP, Mr. Smith contributed to wildlife conservation for nearly a decade, completing field work on rare endemic Hawaiian birds on the Big Island of Hawaii, and raising rare and endangered birds (in some cases, extinct in the wild) at the San Diego Zoo's Avian Propagation Center. Also, Mr. Smith is a former reserve firefighter and EMT for the City of Borrego Springs in California. He holds a Bachelor of Science degree in Ecology and Systematic Biology from Cal Poly San Luis Obispo, California.

      Mr. Smith, his wife, two children, one dog, and one chicken live in an old farmhouse in Massachusetts.

      Session Details:

      PROBLEM-SOLVING ROUNDTABLE DISCUSSIONS

      2024-10-24, 4:15 PM

      Session Details:

      Navigating multiple regulatory agencies to help expedite supply chain times

      2024-10-24, 10:00 AM

      View In Agenda
      Next speaker
      Back
      G Bernard Wandel
      Clinical Trial Patient
      Next speaker
      Back
      Jennifer Sydney Goldman
      Clinical Business Operations Consultant, Day One Biopharmaceuticals

      Session Details:

      PANEL: Funding, investment and budgeting for clinical trials: tips and best practice to ensure success

      2024-10-23, 4:00 PM

      View In Agenda
      Next speaker
      Back
      Charity Roddy
      Associate Director, Patient and Site Experience, Oncology and Rare Disease, Moderna

      Session Details:

      PANEL: How minimizing participant burden leads to on-time enrollment and completion

      2024-10-23, 3:00 PM

      Session Details:

      CASE STUDY: Improving patient and site experience for rare disease trials

      2024-10-24, 11:00 AM

      View In Agenda
      Next speaker

      Plan Your Visit

      Venue

      The Westin Boston Seaport District, USA

      Book Your Stay

      Accommodation

      Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

      Sponsors

      Select a sponsor to learn more

      FEATURED SPONSORS

      SESSION SPONSORS

      TECHNOLOGY SHOWCASE SPONSOR

      ASSOCIATE SPONSORS

      DRINKS RECEPTION

      Lanyard Sponsor

      Prize Draw Sponsor

      Tote Bag Sponsor

      EXHIBITORS

      CO-SPONSORS

      Why partner?

      Contact us to become a partner

      Partnership Opportunities

      We work with you to design a bespoke package to meet your business needs, where you could:

      • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
      • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
        Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
      • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

      Event reach

      • 700+ attendees each year
      • 80% attendees C-suite level

       

      Take a look at our current sponsors

      Media Centre

      MEDIA PARTNERS

      Become A Media Partner

      Your chance to meet and catch up with colleagues from across the industry

      As this event hear from industry leading speakers, learn what is round the corner in terms of future trends and get the latest knowledge on new and upcoming disruptors.

      ▶️ Keynote presentations on the topics affecting you

      ▶️ Join in with audience discussions, panel debates and add your voice to the conversation

       

       

      See What It's All About

      Enquiry

      Contact Us

      SPONSORSHIP ENQUIRIES

      Nicholas McCudden

      Head of OCT events

      +61 280 978 126

      SPEAKER ENQUIRIES

      Louisa Perry

      Portfolio Manager

      MARKETING ENQUIRIES

      Moona Popal

      Marketing Manager

      DELEGATE ENQUIRIES

      Sunny Saikia

      VIP Delegate Manager

      SPONSORSHIP ENQUIRIES

      To enquire about sponsorship opportunities for the conference, please contact:

      Nicholas McCudden

      Head of OCT events


      +61 280 978 126

      SPEAKER ENQUIRES

      To enquire about speaking opportunities for the conference, please contact:

      Louisa Perry

      Portfolio Manager